AI-powered Surreal-GAN identifies diverse brain aging patterns

FHS
August 20, 2024
10:32 am

Researchers utilize ‘Surreal-GAN,’ a deep-representation learning model, to examine the heterogeneity of aging brains.

GSK’s asthma blockbuster Nucala secures win in COPD Phase III trial – Pharmaceutical Technology

GSK anticipates regulatory submission for Europe and Canada in 2025, as per a previous earnings report. Image credit: Shutterstock / OleksSH. GSK’s asthma drug Nucala

September 6, 2024

Rising incidence and mortality rate of hepatocellular carcinoma in the USA: A comprehensive analysis

Over the past two decades, there has been a significant increase in the incidence of primary liver cancer in the USA, with higher rates observed

February 21, 2024

Eckert & Ziegler Again Increases Sales and Earnings in the First Nine Months Compared to Previous Year – Biotech Investments

Eckert & Ziegler SE / Key word(s): 9 Month figures/Preliminary Results Eckert & Ziegler Again Increases Sales and Earnings in the First Nine Months Compared

October 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.